Sylvia Adams

NYU Langone Health

Full Professor(heuristic)

Cancer Immunotherapy and Biomarkers · Oncology

Compare more Oncology professors.

h-index72
i10-index158
Publications349
Citations31,786

Grants

2 total · 0 active

NIH #R01CA161891

Immunomodulation of breast cancer via TLR7 agonist imiquimod and radiotherapy.

Amount
$300K–$400K
Period
2011-09-212015-07-31
PIs
2

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

NIH #K23CA125205

Augmenting Cancer Vaccine Therapy with TLR9 agonists

Amount
$100K–$200K
Period
2007-07-052012-06-30
PIs
1

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

2 total · 0 active

NIH #R01CA161891

Immunomodulation of breast cancer via TLR7 agonist imiquimod and radiotherapy.

Amount
$300K–$400K
Period
2011-09-212015-07-31
PIs
2

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

NIH #K23CA125205

Augmenting Cancer Vaccine Therapy with TLR9 agonists

Amount
$100K–$200K
Period
2007-07-052012-06-30
PIs
1

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

Recent Public Signals

  1. New paper: Evaluation of the gut microbiome and sex hormones in postmenopausal women with newly diagnosed hormone receptor-positive breast cancer versus healthy women: a prospective case-control study (Journal of Cancer Research and Clinical Oncology)2025-10-04

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-08-27

Data may not be current

Find elsewhere

ORCID: 0000-0003-4737-1952

Professor Insights

Career Trajectory